Literature DB >> 27658416

Letter to the Editor: "Risk of venous thromboembolism among patients with vasculitis: a systematic review and meta-analysis".

Andreas Kronbichler1, Jae Il Shin2.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27658416     DOI： 10.1007/s10067-016-3418-3

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN： 0770-3198            Impact factor:   2.980


× No keyword cloud information.
  12 in total

1.  Venous thromboembolic events in systemic vasculitis.

Authors:  Pavel Novikov; Egor Makarov; Sergey Moiseev; Alexey Meshkov; Leonid Strizhakov
Journal:  Ann Rheum Dis       Date:  2014-11-07       Impact factor: 19.103

2.  Risk of pulmonary embolism in patients with autoimmune disorders: a nationwide follow-up study from Sweden.

Authors:  Bengt Zöller; Xinjun Li; Jan Sundquist; Kristina Sundquist
Journal:  Lancet       Date:  2011-11-25       Impact factor: 79.321

3.  Brief communication: high incidence of venous thrombotic events among patients with Wegener granulomatosis: the Wegener's Clinical Occurrence of Thrombosis (WeCLOT) Study.

Authors:  Peter A Merkel; Grace H Lo; Janet T Holbrook; Andrea K Tibbs; Nancy B Allen; John C Davis; Gary S Hoffman; W Joseph McCune; E William St Clair; Ulrich Specks; Robert Spiera; Michelle Petri; John H Stone
Journal:  Ann Intern Med       Date:  2005-04-19       Impact factor: 25.391

4.  Activation of endothelium, coagulation and fibrinolysis is enhanced and associates with renal anti-neutrophil cytoplasmic antibody-associated vasculitis.

Authors:  Anna Salmela; Agneta Ekstrand; Lotta Joutsi-Korhonen; Anne Räisänen-Sokolowski; Riitta Lassila
Journal:  Nephrol Dial Transplant       Date:  2014-12-18       Impact factor: 5.992

Review 5.  Risk of venous thromboembolism among patients with vasculitis: a systematic review and meta-analysis.

Authors:  Patompong Ungprasert; Matthew J Koster; Charat Thongprayoon; Kenneth J Warrington
Journal:  Clin Rheumatol       Date:  2016-08-30       Impact factor: 2.980

6.  Venous thromboembolism in ANCA-associated vasculitis--incidence and risk factors.

Authors:  P M Stassen; R P H Derks; C G M Kallenberg; C A Stegeman
Journal:  Rheumatology (Oxford)       Date:  2008-04       Impact factor: 7.580

7.  Tissue factor expression in neutrophil extracellular traps and neutrophil derived microparticles in antineutrophil cytoplasmic antibody associated vasculitis may promote thromboinflammation and the thrombophilic state associated with the disease.

Authors:  Konstantinos Kambas; Akrivi Chrysanthopoulou; Dimitrios Vassilopoulos; Eirini Apostolidou; Panagiotis Skendros; Andreas Girod; Stella Arelaki; Marios Froudarakis; Lydia Nakopoulou; Alexandra Giatromanolaki; Prodromos Sidiropoulos; Maria Koffa; Dimitrios T Boumpas; Konstantinos Ritis; Ioannis Mitroulis
Journal:  Ann Rheum Dis       Date:  2013-07-19       Impact factor: 19.103

Review 8.  Evaluation and validation of biomarkers in granulomatosis with polyangiitis and microscopic polyangiitis.

Authors:  Andreas Kronbichler; Julia Kerschbaum; Georg Gründlinger; Johannes Leierer; Gert Mayer; Michael Rudnicki
Journal:  Nephrol Dial Transplant       Date:  2015-09-26       Impact factor: 5.992

9.  High frequency of venous thromboembolic events in Churg-Strauss syndrome, Wegener's granulomatosis and microscopic polyangiitis but not polyarteritis nodosa: a systematic retrospective study on 1130 patients.

Authors:  Y Allenbach; R Seror; C Pagnoux; L Teixeira; P Guilpain; L Guillevin
Journal:  Ann Rheum Dis       Date:  2008-11-17       Impact factor: 19.103

10.  High risk of pulmonary embolism and deep venous thrombosis but not of stroke in granulomatosis with polyangiitis (Wegener's).

Authors:  Mikkel Faurschou; Niels Obel; Bo Baslund
Journal:  Arthritis Care Res (Hoboken)       Date:  2014-12       Impact factor: 4.794
View more
  1 in total

1.  Comorbidities in ANCA-associated vasculitis.

Authors:  Andreas Kronbichler; Johannes Leierer; Philipp Gauckler; Jae Il Shin
Journal:  Rheumatology (Oxford)       Date:  2020-05-01       Impact factor: 7.580
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.